Engaging with Representative Groups: what does meaningful PPI look like?

The AI for Multiple Long-Term Conditions Research Support Facility (AIM RSF), a collaborative initiative led by The Alan Turing Institute in partnership with Swansea University, the University of Edinburgh and the University of Oxford, oversees eight research consortia across the UK to support and drive culture change in Multiple Long-Term Condition (MLTC) research. By connecting researchers, healthcare professionals, and patients, AIM RSF has reshaped our understanding of MLTCs.The initiative focuses on five key areas: building robust infrastructure, improving data accessibility, creating a connected research community, engaging with the public, and ensuring lasting impact. As we approach April 2025, marking the conclusion of this phase of the AIM RSF, we reflect on our achievements and the foundation we've laid for future advancements in MLTC research. This case study, the first in a series of three, shares our journey and offers insights and recommendations for those involved in health data research and AI. AIM RSF is funded by the NIHR [Artificial Intelligence for Multiple Long-Term Conditions (AIM) programme (NIHR202647). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-17
DOI
https://doi.org/10.5281/zenodo.15039297
Primary Topic
Ophthalmology and Visual Impairment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Engaging with Representative Groups: what does meaningful PPI look like?

Zenodo (CERN European Organization for Nuclear Research)
Ophthalmology and Visual Impairment Studies
article

Engaging with Representative Groups: what does meaningful PPI look like?

article en

Abstract

The AI for Multiple Long-Term Conditions Research Support Facility (AIM RSF), a collaborative initiative led by The Alan Turing Institute in partnership with Swansea University, the University of Edinburgh and the University of Oxford, oversees eight research consortia across the UK to support and drive culture change in Multiple Long-Term Condition (MLTC) research. By connecting researchers, healthcare professionals, and patients, AIM RSF has reshaped our understanding of MLTCs.The initiative focuses on five key areas: building robust infrastructure, improving data accessibility, creating a connected research community, engaging with the public, and ensuring lasting impact. As we approach April 2025, marking the conclusion of this phase of the AIM RSF, we reflect on our achievements and the foundation we've laid for future advancements in MLTC research. This case study, the first in a series of three, shares our journey and offers insights and recommendations for those involved in health data research and AI. AIM RSF is funded by the NIHR [Artificial Intelligence for Multiple Long-Term Conditions (AIM) programme (NIHR202647). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

Zenodo (CERN European Organization for Nuclear Research)
University of Liverpool (GB), King Abdullah International Medical Research Center (SA)
Industry, innovation and infrastructure
Openalex Percentile: Top 41%
Ophthalmology and Visual Impairment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.